These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8741960)

  • 1. Potentiation of the effects of raclopride on sucrose consumption by the 5-HT2 antagonist ritanserin.
    Montgomery AM; Suri A
    Psychopharmacology (Berl); 1996 Jan; 123(1):98-102. PubMed ID: 8741960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
    Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dopamine antagonists in a two-way active avoidance procedure in rats: interactions with 8-OH-DPAT, ritanserin, and prazosin.
    Prinssen EP; Kleven MS; Koek W
    Psychopharmacology (Berl); 1996 Nov; 128(2):191-7. PubMed ID: 8956380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effects of risperidone, raclopride, and ritanserin on intravenous self-administration of d-amphetamine.
    Fletcher PJ
    Pharmacol Biochem Behav; 1998 May; 60(1):55-60. PubMed ID: 9610924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the rat.
    Wadenberg ML; Salmi P; Jimenez P; Svensson T; Ahlenius S
    Eur Neuropsychopharmacol; 1996 Nov; 6(4):305-10. PubMed ID: 8985714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reward-dependent suppression or facilitation of consummatory behaviour by raclopride.
    Phillips G; Willner P; Muscat R
    Psychopharmacology (Berl); 1991; 105(3):355-60. PubMed ID: 1798832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sweetness-dependent facilitation of sucrose drinking by raclopride is unrelated to calorie content.
    Muscat R; Kyprianou T; Osman M; Phillips G; Willner P
    Pharmacol Biochem Behav; 1991 Oct; 40(2):209-13. PubMed ID: 1805224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-anhedonic actions of the novel serotonergic agent flibanserin, a potential rapidly-acting antidepressant.
    D'Aquila P; Monleon S; Borsini F; Brain P; Willner P
    Eur J Pharmacol; 1997 Dec; 340(2-3):121-32. PubMed ID: 9537806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raclopride decreases sucrose intake of rat pups in independent ingestion tests.
    Tyrka A; Gayle C; Smith GP
    Pharmacol Biochem Behav; 1992 Nov; 43(3):863-9. PubMed ID: 1360164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of microinjection of the D2 dopamine antagonist raclopride into the ventral tegmental area on ethanol and sucrose self-administration.
    Samson HH; Chappell AM
    Alcohol Clin Exp Res; 1999 Mar; 23(3):421-6. PubMed ID: 10195813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression or facilitation of operant behaviour by raclopride dependent on concentration of sucrose reward.
    Phillips G; Willner P; Muscat R
    Psychopharmacology (Berl); 1991; 105(2):239-46. PubMed ID: 1839065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCH23390, but not raclopride, decreases intake of intraorally infused 10% sucrose in adult rats.
    Tyrka A; Smith GP
    Pharmacol Biochem Behav; 1993 May; 45(1):243-6. PubMed ID: 8516366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the rat.
    Wadenberg ML
    J Neural Transm Gen Sect; 1992; 89(1-2):49-59. PubMed ID: 1418867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of water intake and operant responding by dopamine D2 antagonists: raclopride provides important cues for understanding the functional mechanism of action.
    Ljungberg T
    Pharmacol Toxicol; 1989 Jul; 65(1):9-12. PubMed ID: 2780512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of the effects of cocaine on milk consumption in rats by dopamine antagonists.
    Rapoza D; Woolverton WL
    Pharmacol Biochem Behav; 1991 Sep; 40(1):133-7. PubMed ID: 1838194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar effect of raclopride and reduced sucrose concentration on the microstructure of sucrose sham feeding.
    Schneider LH; Davis JD; Watson CA; Smith GP
    Eur J Pharmacol; 1990 Sep; 186(1):61-70. PubMed ID: 2282936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5-HT2 antagonist ritanserin blocks dopamine re-uptake in the rat frontal cortex.
    Ruiu S; Marchese G; Saba PL; Gessa GL; Pani L
    Mol Psychiatry; 2000 Nov; 5(6):673-7. PubMed ID: 11126398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats.
    Uvnäs-Moberg K; Alster P; Svensson TH
    Psychopharmacology (Berl); 1992; 109(4):473-6. PubMed ID: 1365865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a range of dopamine receptor agonists and antagonists on ethanol intake in the rat.
    Silvestre JS; O'Neill MF; Fernandez AG; Palacios JM
    Eur J Pharmacol; 1996 Dec; 318(2-3):257-65. PubMed ID: 9016913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raclopride reduces sucrose preference in rats.
    Hsiao S; Smith GP
    Pharmacol Biochem Behav; 1995 Jan; 50(1):121-5. PubMed ID: 7700947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.